A 7-year-old boy from Tamil Nadu presents with severe hemolytic anemia, hepatosplenomegaly, and bone deformities. Hemoglobin electrophoresis shows absence of β-globin chains. Regarding the pathophysiology of β-thalassemia major, all of the following are true EXCEPT:

Explanation

## Pathophysiology of β-Thalassemia Major ### Normal vs. Thalassemic Globin Chain Synthesis In β-thalassemia major, complete absence of β-globin chain synthesis leads to: - Severe imbalance of α:β globin chains (excess α-globin) - Precipitation of unpaired α-globin chains as Heinz bodies - Oxidative damage to erythroid precursors and mature RBCs ### Key Pathophysiologic Mechanisms **Ineffective Erythropoiesis** - Intramedullary hemolysis of erythroid precursors due to α-globin precipitation - Results in paradoxical reticulocytosis with severe anemia - Accounts for 80–90% of hemolysis in β-thalassemia major **Heinz Body Formation** - Excess α-globin chains precipitate as insoluble inclusions - Cause oxidative damage to RBC membrane and cytoskeleton - Splenic sequestration and destruction of Heinz body–containing cells **Compensatory HbF Production** - Increased γ-globin chain synthesis (HbF = α~2~γ~2~) - HbF does NOT contain β-chains, so it does not suffer from chain imbalance - γ-chains can pair with excess α-chains, reducing precipitation - This is why β-thalassemia intermedia (with HbF production) is less severe than major ### Iron Metabolism in Thalassemia — The Critical Error **Hepcidin is DOWNREGULATED, not upregulated:** | Mechanism | Effect | |-----------|--------| | Chronic hemolysis → chronic anemia | Tissue hypoxia and iron sensing | | Ineffective erythropoiesis | Increased erythroid progenitor signaling (GDF15, TWSG1) | | **Result: Hepcidin suppression** | **Increased intestinal iron absorption** | | Transfusional iron overload | Additional iron burden | **Why hepcidin is suppressed:** - Erythroid progenitors in the bone marrow sense anemia and produce GDF15 (growth differentiation factor 15) - GDF15 and TWSG1 suppress hepcidin transcription via SMAD pathway - This is an **inappropriate** response in the context of transfusional iron overload - Result: uncontrolled intestinal iron absorption despite high serum iron **Key Point:** **Hepcidin is DOWNREGULATED in thalassemia, not upregulated.** The body inappropriately senses anemia (from ineffective erythropoiesis) and increases iron absorption, compounding transfusional iron overload. This is a fundamental pathophysiologic trap. **High-Yield:** The suppression of hepcidin in thalassemia is mediated by **erythroid regulators (GDF15)**, not by the anemia itself. This explains why patients develop secondary hemochromatosis despite chronic anemia. ### Summary Table | Feature | Mechanism | Consequence | |---------|-----------|-------------| | Absent β-globin | Gene deletion/mutation | Chain imbalance | | Excess α-globin | Unpaired α-chains | Heinz body precipitation | | Ineffective erythropoiesis | Intramedullary hemolysis | Severe anemia + reticulocytosis | | HbF compensation | γ-chain synthesis | Partial amelioration | | **Hepcidin suppression** | **GDF15 from erythroblasts** | **Increased Fe absorption** | | Transfusions | Exogenous iron | Iron overload (heart, liver, endocrine) |